Dr. Zhovtis Ryerson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
19555 N 59th Ave
Neptune, NJ 85308Phone+1 732-897-3620
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 2008 - 2011
New York Downtown HospitalInternship, Internal Medicine, 2007 - 2008
University of Rochester School of Medicine and DentistryClass of 2007
Certifications & Licensure
NJ State Medical License 2014 - 2025
NY State Medical License 2008 - 2024- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri) Dosing: NOVA Phase IIIb Extension Study (Part 2).Heinz Wiendl, John Foley, Gilles Defer, Lana Zhovtis Ryerson, Jeffrey A Cohen
Neurology and Therapy. 2024-10-01 - 8 citationsExploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week d...Lana Zhovtis Ryerson, John F Foley, Gilles Defer, Jeffrey A Cohen, Douglas L Arnold
Multiple Sclerosis and Related Disorders. 2023-04-01 - 2 citationsIt's not always an infection: Pyoderma gangrenosum of the urogenital tract in two patients with multiple sclerosis treated with rituximab.Erica Parrotta, Hannah Kopinsky, Jennifer Abate, Lana Zhovtis Ryerson, Lauren B Krupp
Multiple Sclerosis and Related Disorders. 2023-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
